|
|
|
|
Science Sparks @ ACTREC
|
 07th October 2024 |
Vol. No. 13 ; Issue No.651 |
|
|
Publications
|
|
1. Khanna D, Sharma P, Budukh A, Khanna AK (2024). Clinical breast examination: A screening tool for lower- and middle-income countries. Asia-Pacific Journal of Clinical Oncology.
2. Mirikar D, Banerjee N, Prabhash K, Kaushal R, Noronha V, Pramesh CS, Karimundaokal G, Joshi A, Rane S,Basak R (2024). Comparative analysis of EGFR mutations between circulating tumor DNA and tissue samples in non-small cell lung carcinoma patients using BEAMing PCR: results of a single institutional observational study. ResearchSquare.
3. Shetty V, Kashelkar P, Punatar S, Haldipurkar S, Hoshing A, Thakur R, Sankhe P, Tanwar S, Haldipurkar T, Setia MS, Gokarn A, Nayak L, Bonda A, Khattry N (2024). Clinical Manifestations and Outcomes of Ocular Graft Versus Host Disease following Allogeneic Stem Cell Transplantation. Journal of Ophthalmic and Vision Research. 19(3): 284-296.
4. Budrukkar A, Singh M, Swain M, Ghosh-Laskar S, Murthy V, Kale S, Upreti R, Sinha S, Kumar A, Mohanty S, Gupta T, Agarwal JP (2024). Interstitial brachytherapy for periocular nonmelanoma skin cancers: Impact on organ and function preservation. Technical Innovations & Patient Support in Radiation Oncology.
Thesis
Shubhashish Chakraborty. 2024. Structural basis of Eph receptor and ephrin ligand to understand cell-cell signalling and pathogenicity of mutations identified in cancer. (LIFE09201804005) (Guide: Dr. Ashok Varma)
|
|
|
|
|
Interesting Reads
|
|
Bhagwat AS, Torres L, Shestova O, Shestov M, Mellors PW, Fisher HR, Farooki SN, Frost BF, Loken MR, Gaymon AL, Frazee D, Rogal W, Frey N, Hexner EO, Luger SM, Loren AW, Martin ME, McCurdy SR, Perl AE, Stadtmauer EA, Brogdon JL, Fraietta JA, Hwang WT, Siegel DL, Plesa G, Aplenc R, Porter DL, June CH, Gill SI (2024). Cytokine-mediated CAR T therapy resistance in AML. Nature Medicine.
|
|
|
Video of the Week
|
|
| Stem Cells, Tissue Architecture, and Cancer Evolution with applications to the hematopoietic system |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1992, a surgical technique called sentinel lymph node biopsy became a less invasive way to assess whether cancer has spread in patients with early-stage melanoma, the most aggressive form of skin cancer.
|
|
|
|
Cancer News
|
| |
|
|
| |
|
|
|
Researchers develop insights into KRAS mutations in pancreatic cancers.
|
|
EurekAlert, 02/10/2024
|
|
The researchers found that KRAS-G12D, the most common mutation occurring in 35 percent of study patients, was associated with aggressive cancer and the worst outcomes. The variant was also linked with increased rates of distant recurrence, or metastatic disease arising after an operation to remove a tumor...
|
|
|
|
|
|
|
|
|
2024 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
